nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—AGTR1—pancreatic cancer	0.593	1	CbGaD
Candesartan—CYP2C8—Tamoxifen—pancreatic cancer	0.0349	0.139	CbGbCtD
Candesartan—CYP2C8—Erlotinib—pancreatic cancer	0.0297	0.118	CbGbCtD
Candesartan—CYP2C8—Fluorouracil—pancreatic cancer	0.0257	0.102	CbGbCtD
Candesartan—CYP2C9—Tamoxifen—pancreatic cancer	0.0244	0.0969	CbGbCtD
Candesartan—ABCB1—Tamoxifen—pancreatic cancer	0.0236	0.094	CbGbCtD
Candesartan—ABCB1—Gemcitabine—pancreatic cancer	0.0204	0.081	CbGbCtD
Candesartan—ABCB1—Erlotinib—pancreatic cancer	0.0201	0.08	CbGbCtD
Candesartan—ABCB1—Irinotecan—pancreatic cancer	0.0182	0.0722	CbGbCtD
Candesartan—CYP2C9—Fluorouracil—pancreatic cancer	0.018	0.0714	CbGbCtD
Candesartan—ABCB1—Docetaxel—pancreatic cancer	0.0133	0.0529	CbGbCtD
Candesartan—ABCB1—Sunitinib—pancreatic cancer	0.0132	0.0527	CbGbCtD
Candesartan—ABCB1—Doxorubicin—pancreatic cancer	0.00992	0.0395	CbGbCtD
Candesartan—Azilsartan medoxomil—AGTR1—pancreatic cancer	0.00142	0.194	CrCbGaD
Candesartan—Forasartan—AGTR1—pancreatic cancer	0.00132	0.181	CrCbGaD
Candesartan—Tasosartan—AGTR1—pancreatic cancer	0.000802	0.109	CrCbGaD
Candesartan—Valsartan—AGTR1—pancreatic cancer	0.000695	0.0949	CrCbGaD
Candesartan—Olmesartan—AGTR1—pancreatic cancer	0.000678	0.0924	CrCbGaD
Candesartan—Telmisartan—AGTR1—pancreatic cancer	0.000654	0.0892	CrCbGaD
Candesartan—Irbesartan—AGTR1—pancreatic cancer	0.000527	0.0719	CrCbGaD
Candesartan—Pranlukast—TNF—pancreatic cancer	0.000477	0.0651	CrCbGaD
Candesartan—Telmisartan—PPARG—pancreatic cancer	0.000412	0.0561	CrCbGaD
Candesartan—Losartan—AGTR1—pancreatic cancer	0.00034	0.0463	CrCbGaD
Candesartan—Myalgia—Gemcitabine—pancreatic cancer	0.000225	0.00188	CcSEcCtD
Candesartan—Agranulocytosis—Docetaxel—pancreatic cancer	0.000224	0.00187	CcSEcCtD
Candesartan—Asthenia—Erlotinib—pancreatic cancer	0.000222	0.00186	CcSEcCtD
Candesartan—Pruritus—Tamoxifen—pancreatic cancer	0.000222	0.00185	CcSEcCtD
Candesartan—Chest pain—Fluorouracil—pancreatic cancer	0.000221	0.00184	CcSEcCtD
Candesartan—Myalgia—Fluorouracil—pancreatic cancer	0.000221	0.00184	CcSEcCtD
Candesartan—Renal impairment—Epirubicin—pancreatic cancer	0.00022	0.00184	CcSEcCtD
Candesartan—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000219	0.00183	CcSEcCtD
Candesartan—Pruritus—Erlotinib—pancreatic cancer	0.000219	0.00183	CcSEcCtD
Candesartan—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000216	0.00181	CcSEcCtD
Candesartan—Haemoglobin—Docetaxel—pancreatic cancer	0.000216	0.0018	CcSEcCtD
Candesartan—Rhinitis—Docetaxel—pancreatic cancer	0.000216	0.0018	CcSEcCtD
Candesartan—Haemorrhage—Docetaxel—pancreatic cancer	0.000215	0.0018	CcSEcCtD
Candesartan—Hepatitis—Docetaxel—pancreatic cancer	0.000215	0.0018	CcSEcCtD
Candesartan—Cardiac failure—Epirubicin—pancreatic cancer	0.000215	0.00179	CcSEcCtD
Candesartan—Diarrhoea—Tamoxifen—pancreatic cancer	0.000214	0.00179	CcSEcCtD
Candesartan—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000214	0.00179	CcSEcCtD
Candesartan—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000214	0.00178	CcSEcCtD
Candesartan—Pharyngitis—Docetaxel—pancreatic cancer	0.000213	0.00178	CcSEcCtD
Candesartan—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Candesartan—Abdominal pain—Sunitinib—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Candesartan—Body temperature increased—Sunitinib—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Candesartan—Diarrhoea—Erlotinib—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Candesartan—Oedema peripheral—Docetaxel—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Candesartan—Urethral disorder—Docetaxel—pancreatic cancer	0.000211	0.00176	CcSEcCtD
Candesartan—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000211	0.00176	CcSEcCtD
Candesartan—Hyponatraemia—Epirubicin—pancreatic cancer	0.000211	0.00176	CcSEcCtD
Candesartan—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000208	0.00174	CcSEcCtD
Candesartan—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Candesartan—Dizziness—Tamoxifen—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Candesartan—Tachycardia—Fluorouracil—pancreatic cancer	0.000207	0.00172	CcSEcCtD
Candesartan—Hypotension—Irinotecan—pancreatic cancer	0.000207	0.00172	CcSEcCtD
Candesartan—Dizziness—Erlotinib—pancreatic cancer	0.000205	0.00171	CcSEcCtD
Candesartan—Renal impairment—Doxorubicin—pancreatic cancer	0.000204	0.0017	CcSEcCtD
Candesartan—Hypotension—Gemcitabine—pancreatic cancer	0.000201	0.00168	CcSEcCtD
Candesartan—Vomiting—Tamoxifen—pancreatic cancer	0.000199	0.00166	CcSEcCtD
Candesartan—Cardiac failure—Doxorubicin—pancreatic cancer	0.000199	0.00166	CcSEcCtD
Candesartan—Paraesthesia—Irinotecan—pancreatic cancer	0.000198	0.00166	CcSEcCtD
Candesartan—Hypotension—Fluorouracil—pancreatic cancer	0.000198	0.00165	CcSEcCtD
Candesartan—Rash—Tamoxifen—pancreatic cancer	0.000198	0.00165	CcSEcCtD
Candesartan—Dermatitis—Tamoxifen—pancreatic cancer	0.000197	0.00165	CcSEcCtD
Candesartan—Vomiting—Erlotinib—pancreatic cancer	0.000197	0.00165	CcSEcCtD
Candesartan—Dyspnoea—Irinotecan—pancreatic cancer	0.000197	0.00165	CcSEcCtD
Candesartan—Somnolence—Irinotecan—pancreatic cancer	0.000196	0.00164	CcSEcCtD
Candesartan—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000196	0.00164	CcSEcCtD
Candesartan—Headache—Tamoxifen—pancreatic cancer	0.000196	0.00164	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000196	0.00164	CcSEcCtD
Candesartan—Rash—Erlotinib—pancreatic cancer	0.000195	0.00163	CcSEcCtD
Candesartan—Dermatitis—Erlotinib—pancreatic cancer	0.000195	0.00163	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000195	0.00163	CcSEcCtD
Candesartan—Dyspepsia—Irinotecan—pancreatic cancer	0.000195	0.00162	CcSEcCtD
Candesartan—Headache—Erlotinib—pancreatic cancer	0.000194	0.00162	CcSEcCtD
Candesartan—Paraesthesia—Gemcitabine—pancreatic cancer	0.000193	0.00161	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000193	0.00161	CcSEcCtD
Candesartan—Asthenia—Sunitinib—pancreatic cancer	0.000193	0.00161	CcSEcCtD
Candesartan—Dyspnoea—Gemcitabine—pancreatic cancer	0.000192	0.0016	CcSEcCtD
Candesartan—Somnolence—Gemcitabine—pancreatic cancer	0.000191	0.0016	CcSEcCtD
Candesartan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000191	0.00159	CcSEcCtD
Candesartan—Fatigue—Irinotecan—pancreatic cancer	0.000191	0.00159	CcSEcCtD
Candesartan—Paraesthesia—Fluorouracil—pancreatic cancer	0.00019	0.00159	CcSEcCtD
Candesartan—Pruritus—Sunitinib—pancreatic cancer	0.00019	0.00158	CcSEcCtD
Candesartan—Dyspnoea—Fluorouracil—pancreatic cancer	0.000189	0.00158	CcSEcCtD
Candesartan—Mental disorder—Docetaxel—pancreatic cancer	0.000188	0.00157	CcSEcCtD
Candesartan—Somnolence—Fluorouracil—pancreatic cancer	0.000188	0.00157	CcSEcCtD
Candesartan—Malnutrition—Docetaxel—pancreatic cancer	0.000187	0.00156	CcSEcCtD
Candesartan—Dyspepsia—Fluorouracil—pancreatic cancer	0.000186	0.00156	CcSEcCtD
Candesartan—Nausea—Tamoxifen—pancreatic cancer	0.000186	0.00155	CcSEcCtD
Candesartan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000186	0.00155	CcSEcCtD
Candesartan—Fatigue—Gemcitabine—pancreatic cancer	0.000186	0.00155	CcSEcCtD
Candesartan—Nausea—Erlotinib—pancreatic cancer	0.000184	0.00154	CcSEcCtD
Candesartan—Diarrhoea—Sunitinib—pancreatic cancer	0.000184	0.00153	CcSEcCtD
Candesartan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000183	0.00153	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000182	0.00152	CcSEcCtD
Candesartan—Back pain—Docetaxel—pancreatic cancer	0.000181	0.00151	CcSEcCtD
Candesartan—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000181	0.00151	CcSEcCtD
Candesartan—Dizziness—Sunitinib—pancreatic cancer	0.000177	0.00148	CcSEcCtD
Candesartan—Angina pectoris—Epirubicin—pancreatic cancer	0.000177	0.00147	CcSEcCtD
Candesartan—Abdominal pain—Irinotecan—pancreatic cancer	0.000175	0.00146	CcSEcCtD
Candesartan—Body temperature increased—Irinotecan—pancreatic cancer	0.000175	0.00146	CcSEcCtD
Candesartan—Bronchitis—Epirubicin—pancreatic cancer	0.000174	0.00146	CcSEcCtD
Candesartan—Anaemia—Docetaxel—pancreatic cancer	0.000173	0.00144	CcSEcCtD
Candesartan—Vomiting—Sunitinib—pancreatic cancer	0.000171	0.00142	CcSEcCtD
Candesartan—Body temperature increased—Gemcitabine—pancreatic cancer	0.00017	0.00142	CcSEcCtD
Candesartan—Neutropenia—Epirubicin—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Candesartan—Rash—Sunitinib—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Candesartan—Dermatitis—Sunitinib—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Candesartan—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000168	0.00141	CcSEcCtD
Candesartan—Urticaria—Fluorouracil—pancreatic cancer	0.000168	0.0014	CcSEcCtD
Candesartan—Headache—Sunitinib—pancreatic cancer	0.000168	0.0014	CcSEcCtD
Candesartan—Leukopenia—Docetaxel—pancreatic cancer	0.000168	0.0014	CcSEcCtD
Candesartan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000167	0.0014	CcSEcCtD
Candesartan—Palpitations—Docetaxel—pancreatic cancer	0.000165	0.00138	CcSEcCtD
Candesartan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000163	0.00136	CcSEcCtD
Candesartan—Cough—Docetaxel—pancreatic cancer	0.000163	0.00136	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—pancreatic cancer	0.000163	0.00136	CcSEcCtD
Candesartan—Hypertension—Docetaxel—pancreatic cancer	0.000162	0.00135	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—pancreatic cancer	0.000161	0.00135	CcSEcCtD
Candesartan—Arthralgia—Docetaxel—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Candesartan—Myalgia—Docetaxel—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Candesartan—Chest pain—Docetaxel—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Candesartan—Nausea—Sunitinib—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Candesartan—Renal failure—Epirubicin—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Candesartan—Asthenia—Irinotecan—pancreatic cancer	0.000159	0.00132	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—pancreatic cancer	0.000157	0.00131	CcSEcCtD
Candesartan—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000156	0.0013	CcSEcCtD
Candesartan—Asthenia—Gemcitabine—pancreatic cancer	0.000154	0.00129	CcSEcCtD
Candesartan—Haematuria—Epirubicin—pancreatic cancer	0.000154	0.00129	CcSEcCtD
Candesartan—Epistaxis—Epirubicin—pancreatic cancer	0.000152	0.00127	CcSEcCtD
Candesartan—Pruritus—Gemcitabine—pancreatic cancer	0.000152	0.00127	CcSEcCtD
Candesartan—Sinusitis—Epirubicin—pancreatic cancer	0.000152	0.00127	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000151	0.00126	CcSEcCtD
Candesartan—Diarrhoea—Irinotecan—pancreatic cancer	0.000151	0.00126	CcSEcCtD
Candesartan—Agranulocytosis—Epirubicin—pancreatic cancer	0.000151	0.00126	CcSEcCtD
Candesartan—Pruritus—Fluorouracil—pancreatic cancer	0.00015	0.00125	CcSEcCtD
Candesartan—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00015	0.00125	CcSEcCtD
Candesartan—Tachycardia—Docetaxel—pancreatic cancer	0.000149	0.00124	CcSEcCtD
Candesartan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000147	0.00123	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—pancreatic cancer	0.000147	0.00123	CcSEcCtD
Candesartan—Dizziness—Irinotecan—pancreatic cancer	0.000146	0.00122	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—pancreatic cancer	0.000146	0.00122	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—pancreatic cancer	0.000145	0.00121	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—pancreatic cancer	0.000145	0.00121	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—pancreatic cancer	0.000145	0.00121	CcSEcCtD
Candesartan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000145	0.00121	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—pancreatic cancer	0.000144	0.0012	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000143	0.0012	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—pancreatic cancer	0.000143	0.00119	CcSEcCtD
Candesartan—Hypotension—Docetaxel—pancreatic cancer	0.000143	0.00119	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—pancreatic cancer	0.000143	0.00119	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—pancreatic cancer	0.000142	0.00119	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—pancreatic cancer	0.000141	0.00118	CcSEcCtD
Candesartan—Vomiting—Irinotecan—pancreatic cancer	0.000141	0.00117	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—pancreatic cancer	0.00014	0.00117	CcSEcCtD
Candesartan—Dizziness—Fluorouracil—pancreatic cancer	0.00014	0.00117	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00014	0.00116	CcSEcCtD
Candesartan—Rash—Irinotecan—pancreatic cancer	0.000139	0.00116	CcSEcCtD
Candesartan—Dermatitis—Irinotecan—pancreatic cancer	0.000139	0.00116	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000139	0.00116	CcSEcCtD
Candesartan—Headache—Irinotecan—pancreatic cancer	0.000138	0.00116	CcSEcCtD
Candesartan—Paraesthesia—Docetaxel—pancreatic cancer	0.000137	0.00115	CcSEcCtD
Candesartan—Vomiting—Gemcitabine—pancreatic cancer	0.000137	0.00114	CcSEcCtD
Candesartan—Dyspnoea—Docetaxel—pancreatic cancer	0.000136	0.00114	CcSEcCtD
Candesartan—Somnolence—Docetaxel—pancreatic cancer	0.000136	0.00113	CcSEcCtD
Candesartan—Rash—Gemcitabine—pancreatic cancer	0.000136	0.00113	CcSEcCtD
Candesartan—Dermatitis—Gemcitabine—pancreatic cancer	0.000136	0.00113	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—pancreatic cancer	0.000135	0.00113	CcSEcCtD
Candesartan—Headache—Gemcitabine—pancreatic cancer	0.000135	0.00113	CcSEcCtD
Candesartan—Vomiting—Fluorouracil—pancreatic cancer	0.000135	0.00112	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—pancreatic cancer	0.000135	0.00112	CcSEcCtD
Candesartan—Dyspepsia—Docetaxel—pancreatic cancer	0.000134	0.00112	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—pancreatic cancer	0.000134	0.00112	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—pancreatic cancer	0.000134	0.00112	CcSEcCtD
Candesartan—Rash—Fluorouracil—pancreatic cancer	0.000133	0.00111	CcSEcCtD
Candesartan—Dermatitis—Fluorouracil—pancreatic cancer	0.000133	0.00111	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—pancreatic cancer	0.000133	0.00111	CcSEcCtD
Candesartan—Headache—Fluorouracil—pancreatic cancer	0.000133	0.00111	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000133	0.00111	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000132	0.0011	CcSEcCtD
Candesartan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000132	0.0011	CcSEcCtD
Candesartan—Fatigue—Docetaxel—pancreatic cancer	0.000132	0.0011	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—pancreatic cancer	0.000132	0.0011	CcSEcCtD
Candesartan—Nausea—Irinotecan—pancreatic cancer	0.000131	0.0011	CcSEcCtD
Candesartan—Nausea—Gemcitabine—pancreatic cancer	0.000128	0.00107	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—pancreatic cancer	0.000127	0.00106	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—pancreatic cancer	0.000126	0.00105	CcSEcCtD
Candesartan—Nausea—Fluorouracil—pancreatic cancer	0.000126	0.00105	CcSEcCtD
Candesartan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000125	0.00104	CcSEcCtD
Candesartan—Back pain—Epirubicin—pancreatic cancer	0.000122	0.00102	CcSEcCtD
Candesartan—Body temperature increased—Docetaxel—pancreatic cancer	0.000121	0.00101	CcSEcCtD
Candesartan—Abdominal pain—Docetaxel—pancreatic cancer	0.000121	0.00101	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—pancreatic cancer	0.000118	0.000982	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—pancreatic cancer	0.000117	0.000975	CcSEcCtD
Candesartan—Anaemia—Epirubicin—pancreatic cancer	0.000117	0.000974	CcSEcCtD
Candesartan—Vertigo—Epirubicin—pancreatic cancer	0.000113	0.000947	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—pancreatic cancer	0.000113	0.000944	CcSEcCtD
Candesartan—Back pain—Doxorubicin—pancreatic cancer	0.000113	0.000944	CcSEcCtD
Candesartan—Palpitations—Epirubicin—pancreatic cancer	0.000112	0.000932	CcSEcCtD
Candesartan—Cough—Epirubicin—pancreatic cancer	0.00011	0.00092	CcSEcCtD
Candesartan—Asthenia—Docetaxel—pancreatic cancer	0.00011	0.000915	CcSEcCtD
Candesartan—Hypertension—Epirubicin—pancreatic cancer	0.000109	0.00091	CcSEcCtD
Candesartan—Pruritus—Docetaxel—pancreatic cancer	0.000108	0.000902	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—pancreatic cancer	0.000108	0.000902	CcSEcCtD
Candesartan—Chest pain—Epirubicin—pancreatic cancer	0.000107	0.000897	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—pancreatic cancer	0.000107	0.000897	CcSEcCtD
Candesartan—Myalgia—Epirubicin—pancreatic cancer	0.000107	0.000897	CcSEcCtD
Candesartan—Anxiety—Epirubicin—pancreatic cancer	0.000107	0.000894	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—pancreatic cancer	0.000105	0.000876	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—pancreatic cancer	0.000105	0.000873	CcSEcCtD
Candesartan—Diarrhoea—Docetaxel—pancreatic cancer	0.000105	0.000873	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—pancreatic cancer	0.000103	0.000862	CcSEcCtD
Candesartan—Cough—Doxorubicin—pancreatic cancer	0.000102	0.000851	CcSEcCtD
Candesartan—Dizziness—Docetaxel—pancreatic cancer	0.000101	0.000844	CcSEcCtD
Candesartan—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000101	0.000842	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—pancreatic cancer	0.000101	0.000842	CcSEcCtD
Candesartan—Tachycardia—Epirubicin—pancreatic cancer	0.000101	0.00084	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—pancreatic cancer	9.96e-05	0.000832	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—pancreatic cancer	9.95e-05	0.00083	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—pancreatic cancer	9.95e-05	0.00083	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—pancreatic cancer	9.95e-05	0.00083	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—pancreatic cancer	9.91e-05	0.000828	CcSEcCtD
Candesartan—Vomiting—Docetaxel—pancreatic cancer	9.71e-05	0.000811	CcSEcCtD
Candesartan—Rash—Docetaxel—pancreatic cancer	9.63e-05	0.000804	CcSEcCtD
Candesartan—Hypotension—Epirubicin—pancreatic cancer	9.63e-05	0.000804	CcSEcCtD
Candesartan—Dermatitis—Docetaxel—pancreatic cancer	9.62e-05	0.000804	CcSEcCtD
Candesartan—Headache—Docetaxel—pancreatic cancer	9.57e-05	0.000799	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.39e-05	0.000784	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.34e-05	0.000779	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—pancreatic cancer	9.31e-05	0.000777	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—pancreatic cancer	9.25e-05	0.000773	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.22e-05	0.00077	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—pancreatic cancer	9.19e-05	0.000767	CcSEcCtD
Candesartan—Somnolence—Epirubicin—pancreatic cancer	9.16e-05	0.000765	CcSEcCtD
Candesartan—Nausea—Docetaxel—pancreatic cancer	9.08e-05	0.000758	CcSEcCtD
Candesartan—Dyspepsia—Epirubicin—pancreatic cancer	9.07e-05	0.000757	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—pancreatic cancer	8.91e-05	0.000744	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.9e-05	0.000743	CcSEcCtD
Candesartan—Fatigue—Epirubicin—pancreatic cancer	8.88e-05	0.000742	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.69e-05	0.000725	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—pancreatic cancer	8.56e-05	0.000715	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—pancreatic cancer	8.5e-05	0.00071	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—pancreatic cancer	8.48e-05	0.000708	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.43e-05	0.000704	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—pancreatic cancer	8.39e-05	0.000701	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.23e-05	0.000687	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—pancreatic cancer	8.22e-05	0.000686	CcSEcCtD
Candesartan—Urticaria—Epirubicin—pancreatic cancer	8.19e-05	0.000683	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—pancreatic cancer	8.15e-05	0.00068	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—pancreatic cancer	8.15e-05	0.00068	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.8e-05	0.000651	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—pancreatic cancer	7.57e-05	0.000632	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—pancreatic cancer	7.54e-05	0.000629	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—pancreatic cancer	7.54e-05	0.000629	CcSEcCtD
Candesartan—Asthenia—Epirubicin—pancreatic cancer	7.39e-05	0.000617	CcSEcCtD
Candesartan—Pruritus—Epirubicin—pancreatic cancer	7.29e-05	0.000609	CcSEcCtD
Candesartan—Diarrhoea—Epirubicin—pancreatic cancer	7.05e-05	0.000589	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—pancreatic cancer	6.84e-05	0.000571	CcSEcCtD
Candesartan—Dizziness—Epirubicin—pancreatic cancer	6.81e-05	0.000569	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—pancreatic cancer	6.75e-05	0.000563	CcSEcCtD
Candesartan—Vomiting—Epirubicin—pancreatic cancer	6.55e-05	0.000547	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—pancreatic cancer	6.52e-05	0.000545	CcSEcCtD
Candesartan—Rash—Epirubicin—pancreatic cancer	6.5e-05	0.000542	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—pancreatic cancer	6.49e-05	0.000542	CcSEcCtD
Candesartan—Headache—Epirubicin—pancreatic cancer	6.46e-05	0.000539	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—pancreatic cancer	6.31e-05	0.000526	CcSEcCtD
Candesartan—Nausea—Epirubicin—pancreatic cancer	6.12e-05	0.000511	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—pancreatic cancer	6.06e-05	0.000506	CcSEcCtD
Candesartan—Rash—Doxorubicin—pancreatic cancer	6.01e-05	0.000502	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—pancreatic cancer	6.01e-05	0.000501	CcSEcCtD
Candesartan—Headache—Doxorubicin—pancreatic cancer	5.97e-05	0.000499	CcSEcCtD
Candesartan—Nausea—Doxorubicin—pancreatic cancer	5.66e-05	0.000473	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—ACVR1B—pancreatic cancer	5.08e-05	0.00179	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.99e-05	0.00176	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PTHLH—pancreatic cancer	4.92e-05	0.00173	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ARG2—pancreatic cancer	4.88e-05	0.00172	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—SHH—pancreatic cancer	4.71e-05	0.00166	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IAPP—pancreatic cancer	4.65e-05	0.00164	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DTX1—pancreatic cancer	4.59e-05	0.00162	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SSTR3—pancreatic cancer	4.59e-05	0.00162	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	4.53e-05	0.0016	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—SST—pancreatic cancer	4.5e-05	0.00158	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTHLH—pancreatic cancer	4.47e-05	0.00157	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTCH1—pancreatic cancer	4.47e-05	0.00157	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	4.46e-05	0.00157	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	4.41e-05	0.00155	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SSTR1—pancreatic cancer	4.4e-05	0.00155	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PPY—pancreatic cancer	4.32e-05	0.00152	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TYMP—pancreatic cancer	4.26e-05	0.0015	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SSTR2—pancreatic cancer	4.24e-05	0.00149	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CNR1—pancreatic cancer	4.15e-05	0.00146	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCKBR—pancreatic cancer	4.09e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—SST—pancreatic cancer	4.08e-05	0.00144	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	4.08e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	4.07e-05	0.00143	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	4.02e-05	0.00141	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GCG—pancreatic cancer	4.01e-05	0.00141	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	3.94e-05	0.00139	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	3.9e-05	0.00137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DTX4—pancreatic cancer	3.85e-05	0.00136	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GLI1—pancreatic cancer	3.85e-05	0.00136	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	3.82e-05	0.00134	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	3.8e-05	0.00134	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CNR1—pancreatic cancer	3.77e-05	0.00133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NRP1—pancreatic cancer	3.74e-05	0.00132	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PPP2R5B—pancreatic cancer	3.74e-05	0.00132	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GCG—pancreatic cancer	3.64e-05	0.00128	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HEY2—pancreatic cancer	3.6e-05	0.00127	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	3.59e-05	0.00127	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GAST—pancreatic cancer	3.52e-05	0.00124	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	3.49e-05	0.00123	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	3.45e-05	0.00121	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	3.44e-05	0.00121	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GLP1R—pancreatic cancer	3.44e-05	0.00121	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—DPYD—pancreatic cancer	3.38e-05	0.00119	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	3.37e-05	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	3.34e-05	0.00118	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SCT—pancreatic cancer	3.34e-05	0.00117	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HEY1—pancreatic cancer	3.34e-05	0.00117	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	3.28e-05	0.00116	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.23e-05	0.00114	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SLC2A2—pancreatic cancer	3.21e-05	0.00113	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCK—pancreatic cancer	3.18e-05	0.00112	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PRSS1—pancreatic cancer	3.17e-05	0.00112	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR2—pancreatic cancer	3.1e-05	0.00109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GLP1R—pancreatic cancer	3.1e-05	0.00109	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—pancreatic cancer	3.1e-05	0.00109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCKAR—pancreatic cancer	3.05e-05	0.00107	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAG2—pancreatic cancer	2.96e-05	0.00104	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.92e-05	0.00103	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MEN1—pancreatic cancer	2.92e-05	0.00103	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SHH—pancreatic cancer	2.78e-05	0.00098	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH4—pancreatic cancer	2.77e-05	0.000974	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IAPP—pancreatic cancer	2.75e-05	0.000967	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ARG2—pancreatic cancer	2.75e-05	0.000967	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.68e-05	0.000943	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTHLH—pancreatic cancer	2.64e-05	0.000929	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTCH1—pancreatic cancer	2.64e-05	0.000929	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—pancreatic cancer	2.5e-05	0.000881	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.49e-05	0.000876	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CD44—pancreatic cancer	2.48e-05	0.000874	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SST—pancreatic cancer	2.41e-05	0.000849	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMP—pancreatic cancer	2.4e-05	0.000845	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.38e-05	0.000838	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GCG—pancreatic cancer	2.38e-05	0.000838	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.38e-05	0.000838	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAG1—pancreatic cancer	2.36e-05	0.000831	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH3—pancreatic cancer	2.35e-05	0.000828	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—STK11—pancreatic cancer	2.24e-05	0.000788	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR1—pancreatic cancer	2.23e-05	0.000784	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.17e-05	0.000764	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.16e-05	0.000761	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.15e-05	0.000757	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GCG—pancreatic cancer	2.15e-05	0.000757	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.09e-05	0.000736	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PRSS1—pancreatic cancer	2.05e-05	0.00072	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STK11—pancreatic cancer	2.02e-05	0.000712	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.98e-05	0.000697	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GLP1R—pancreatic cancer	1.93e-05	0.000681	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TYMS—pancreatic cancer	1.93e-05	0.000678	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—DPYD—pancreatic cancer	1.9e-05	0.00067	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.9e-05	0.000669	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.83e-05	0.000644	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.82e-05	0.000642	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A2—pancreatic cancer	1.81e-05	0.000636	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.79e-05	0.000629	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.78e-05	0.000628	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.77e-05	0.000625	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SMAD4—pancreatic cancer	1.77e-05	0.000623	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.75e-05	0.000617	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HES1—pancreatic cancer	1.73e-05	0.000609	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.73e-05	0.000607	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.7e-05	0.000598	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.67e-05	0.000586	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.66e-05	0.000583	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.65e-05	0.000582	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.64e-05	0.000576	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.6e-05	0.000562	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—pancreatic cancer	1.59e-05	0.00056	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.57e-05	0.000553	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—pancreatic cancer	1.57e-05	0.000551	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.55e-05	0.000546	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ARG2—pancreatic cancer	1.55e-05	0.000544	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—pancreatic cancer	1.52e-05	0.000533	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.48e-05	0.000521	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HIF1A—pancreatic cancer	1.45e-05	0.00051	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC2—pancreatic cancer	1.45e-05	0.000509	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.44e-05	0.000508	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.44e-05	0.000507	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—pancreatic cancer	1.41e-05	0.000498	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—pancreatic cancer	1.41e-05	0.000498	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD44—pancreatic cancer	1.4e-05	0.000493	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KDR—pancreatic cancer	1.39e-05	0.000488	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.37e-05	0.000482	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—pancreatic cancer	1.36e-05	0.00048	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.36e-05	0.000478	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMP—pancreatic cancer	1.35e-05	0.000476	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GCG—pancreatic cancer	1.34e-05	0.000472	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.33e-05	0.000467	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.32e-05	0.000466	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKBIA—pancreatic cancer	1.32e-05	0.000464	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH1—pancreatic cancer	1.31e-05	0.00046	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.3e-05	0.000456	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.28e-05	0.00045	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—pancreatic cancer	1.28e-05	0.000449	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—NRAS—pancreatic cancer	1.28e-05	0.000449	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.26e-05	0.000444	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGF—pancreatic cancer	1.26e-05	0.000444	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—STK11—pancreatic cancer	1.26e-05	0.000444	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.25e-05	0.00044	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	1.24e-05	0.000437	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.23e-05	0.000435	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.23e-05	0.000433	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.22e-05	0.000431	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.18e-05	0.000417	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.17e-05	0.000411	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—pancreatic cancer	1.16e-05	0.000409	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.15e-05	0.000407	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.13e-05	0.000396	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.12e-05	0.000395	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.11e-05	0.000392	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.11e-05	0.000391	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—pancreatic cancer	1.1e-05	0.000387	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.09e-05	0.000383	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.09e-05	0.000383	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMS—pancreatic cancer	1.08e-05	0.000382	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	1.08e-05	0.000381	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—pancreatic cancer	1.07e-05	0.000378	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DPYD—pancreatic cancer	1.07e-05	0.000377	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.04e-05	0.000367	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.02e-05	0.000358	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.02e-05	0.000358	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.02e-05	0.000357	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.01e-05	0.000355	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DPYD—pancreatic cancer	1e-05	0.000352	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—pancreatic cancer	9.78e-06	0.000344	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.5e-06	0.000334	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—pancreatic cancer	9.4e-06	0.000331	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.4e-06	0.000331	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—pancreatic cancer	9.36e-06	0.00033	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—pancreatic cancer	9.34e-06	0.000329	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	9.19e-06	0.000324	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—pancreatic cancer	9.08e-06	0.00032	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.07e-06	0.000319	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD44—pancreatic cancer	9.04e-06	0.000318	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—pancreatic cancer	9e-06	0.000317	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.85e-06	0.000312	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—pancreatic cancer	8.82e-06	0.000311	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.77e-06	0.000309	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—pancreatic cancer	8.76e-06	0.000308	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—pancreatic cancer	8.67e-06	0.000305	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCG—pancreatic cancer	8.66e-06	0.000305	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—pancreatic cancer	8.5e-06	0.000299	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—pancreatic cancer	8.45e-06	0.000298	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.35e-06	0.000294	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.26e-06	0.000291	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—pancreatic cancer	8.25e-06	0.00029	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—STK11—pancreatic cancer	8.15e-06	0.000287	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—pancreatic cancer	7.96e-06	0.00028	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD44—pancreatic cancer	7.87e-06	0.000277	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SRC—pancreatic cancer	7.84e-06	0.000276	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—pancreatic cancer	7.68e-06	0.000271	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.65e-06	0.000269	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—pancreatic cancer	7.63e-06	0.000269	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—pancreatic cancer	7.56e-06	0.000266	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCG—pancreatic cancer	7.55e-06	0.000266	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NRAS—pancreatic cancer	7.54e-06	0.000265	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD44—pancreatic cancer	7.35e-06	0.000259	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.2e-06	0.000254	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.14e-06	0.000251	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—STK11—pancreatic cancer	7.1e-06	0.00025	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCG—pancreatic cancer	7.05e-06	0.000248	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—pancreatic cancer	7.02e-06	0.000247	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—pancreatic cancer	7.01e-06	0.000247	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMS—pancreatic cancer	7.01e-06	0.000247	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—pancreatic cancer	7e-06	0.000246	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—pancreatic cancer	6.87e-06	0.000242	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—STK11—pancreatic cancer	6.63e-06	0.000233	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	6.6e-06	0.000232	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—pancreatic cancer	6.49e-06	0.000228	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.22e-06	0.000219	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMS—pancreatic cancer	6.1e-06	0.000215	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—pancreatic cancer	6.1e-06	0.000215	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—pancreatic cancer	6.04e-06	0.000213	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—pancreatic cancer	5.96e-06	0.00021	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—pancreatic cancer	5.77e-06	0.000203	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.7e-06	0.000201	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—pancreatic cancer	5.7e-06	0.000201	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—pancreatic cancer	5.52e-06	0.000194	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.39e-06	0.00019	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—pancreatic cancer	5.39e-06	0.00019	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—pancreatic cancer	5.27e-06	0.000186	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	5.14e-06	0.000181	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—pancreatic cancer	4.96e-06	0.000175	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.96e-06	0.000175	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—pancreatic cancer	4.87e-06	0.000171	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—pancreatic cancer	4.64e-06	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.52e-06	0.000159	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.48e-06	0.000158	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.39e-06	0.000155	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—pancreatic cancer	4.32e-06	0.000152	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.19e-06	0.000147	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.04e-06	0.000142	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.94e-06	0.000139	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.94e-06	0.000139	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.9e-06	0.000137	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—pancreatic cancer	3.72e-06	0.000131	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.68e-06	0.00013	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.43e-06	0.000121	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.41e-06	0.00012	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.4e-06	0.00012	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.21e-06	0.000113	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.18e-06	0.000112	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—pancreatic cancer	3.04e-06	0.000107	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—pancreatic cancer	2.97e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.77e-06	9.76e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.4e-06	8.46e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.09e-06	7.37e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.96e-06	6.91e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.96e-06	6.88e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—pancreatic cancer	1.71e-06	6.02e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.6e-06	5.62e-05	CbGpPWpGaD
